Marketing Authorizations (MA) are of vital importance in the disinfection sector. They ensure that disinfectant products meet safety and effectiveness standards established by regulatory authorities. These authorizations attest to the conformity of products with health and environmental requirements, thus ensuring the protection of users, patients and the environment against the risks linked to the use of disinfectant products. AMMs promote confidence in disinfectant products among healthcare professionals and the general public, thereby helping to ensure safe and effective disinfection practices.
The marketing authorization granted to Oxy’Pharm for its airborne disinfection process validates its effectiveness, demonstrating its superiority compared to other existing methods.
Like medicines, disinfection products require a Marketing Authorization (MA) to be obtained before being marketed. Oxy’Pharm undertook the process of obtaining marketing authorization for its airborne disinfection product in 2017, and after several years of rigorous evaluation, authorization was obtained in 2023. This process includes several phases: The first is research and development, where the product is developed and tested in the laboratory. Next comes the preclinical phase, during which the safety and effectiveness of the product are evaluated. The MA file is subsequently submitted to the regulatory authorities, who carefully examine the scientific data provided.
Secondly, the product goes through the clinical phase. This step is decisive since it validates, or not, the effectiveness tested in the pre-clinical phase and makes it possible to evaluate the tolerance of the product on human volunteers. Finally, once all regulatory requirements are met, Marketing Authorization is granted, allowing the company to legally market its product. In the case of the Oxy’Pharm airborne disinfection process, obtaining this Marketing Authorization guarantees the effectiveness and safety of the product, thus ensuring the protection of public health.
TOWARDS GREATER OPENING ON THE EUROPEAN MARKET
The Marketing Authorization (AMM) granted to Oxy’Pharm for its airborne disinfection process extends to all countries of the European Union. This Marketing Authorization gives Oxy’Pharm the right to market its disinfection products in all EU member countries, in accordance with current European standards and regulations. Thanks to this authorization, Oxy’Pharm has been able, since October 2023, to introduce its products to the European market without having to request specific authorizations for each country. The marketing process in Europe is thus simplified, which promotes the accessibility of Oxy’Pharm disinfection solutions to a wider audience. This approach demonstrates the company’s commitment to providing quality products that meet the highest standards for disinfection, while ensuring safety and regulatory compliance in all countries where its products are marketed.
ECO-RESPONSIBILITY AT THE HEART OF AIR DISINFECTION
on the treated surfaces. This environmentally friendly approach guarantees complete and safe disinfection while minimizing the impact on the ecosystem. As a result, Oxy’Pharm’s airborne disinfection process represents an innovative and sustainable solution to ensure healthy and safe environments in a variety of settings, ranging from hospitals and food industries to public spaces and transportation.
AIR SURFACE DISINFECTION: A WIDE AND HOMOGENEOUS SPECTRUM COMBINED WITH A PRINCIPLE OF ECO-RESPONSIBILITY
Oxy’Pharm’s airborne disinfection process represents a complete and effective solution for eliminating pathogens. As a bactericide, it targets and eradicates the bacteria present. As a fungicide, it fights against fungi and mold, thus preserving indoor air quality. Its virucidal action also helps eliminate viruses, including enveloped and naked viruses, providing additional protection against viral infections. As a sporicide, it is effective against microbial spores, providing deep disinfection. Finally, as a mycobactericide, it eliminates mycobacteria, including the dreaded Mycobacterium tuberculosis. This versatility makes it the ideal disinfectant product to ensure a healthy and safe environment in various settings, from hospitals to offices to public spaces.
